Cargando…
Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway
ETHNOPHARMACOLOGICAL RELEVANCE: Acute lung injury (ALI) is one of the fatal complications of respiratory virus infections such as influenza virus and coronavirus, which has high clinical morbidity and mortality. Jinhua Qinggan granules (JHQG) has been approved by China Food and Drug Administration i...
Autores principales: | Zhu, Yanhui, Han, Qianqian, Wang, Lei, Wang, Baiyan, Chen, Jianshuang, Cai, Bangrong, Wu, Can, Zhu, Xiali, Liu, Fugang, Han, Deen, Dong, Haoran, Jia, Yongyan, Liu, Yalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523948/ https://www.ncbi.nlm.nih.gov/pubmed/36183949 http://dx.doi.org/10.1016/j.jep.2022.115763 |
Ejemplares similares
-
Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial
por: An, XueDong, et al.
Publicado: (2021) -
Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
por: Shah, Muhammad Raza, et al.
Publicado: (2022) -
Efficacy and safety of Jinhua Qinggan granules in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
por: Si, Xiuying, et al.
Publicado: (2023) -
Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and meta-analysis
por: Chen, Hao, et al.
Publicado: (2020) -
The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis
por: Zhang, Qiongshuai, et al.
Publicado: (2020)